Word

TARGETSCAPE

Status

Registered

Status Code

700

Status Date

Tuesday, March 17, 2020

Serial Number

79271806

Registration Number

6010552

Registration Date

Tuesday, March 17, 2020

Mark Type

5000

Filing Date

Wednesday, August 14, 2019

Published for Opposition

Tuesday, December 31, 2019

Trademark Owner History

IMMUNOSCAPE PTE. LTD. - Original Registrant

Classifications

1 Laboratory reagents for scientific use; laboratory reagents for scientific use; reagents for laboratory purposes, other than for medical or veterinary purposes; reagents and reagents in kit form for scientific research use; diagnostic biochemical, chemical and biological reagents for laboratory or scientific purposes, other than for medical or veterinary use; reagents for use in biological analysis; reagents and reagents in kit form for immune profiling

42 Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple t cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional t cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system

Color is not claimed as a feature of the mark.
TARGET SCAPE

Trademark Events

May 15, 2020

Notification Processed By Ib

Apr 28, 2020

Final Disposition Notice Sent To Ib

Apr 28, 2020

Final Disposition Processed

Apr 16, 2020

Grant Of Protection Created, To Be Sent To Ib

Mar 17, 2020

Registered-Principal Register

Jan 4, 2020

Notification Processed By Ib

Dec 31, 2019

Published For Opposition

Dec 18, 2019

Notification Of Possible Opposition Sent To Ib

Dec 18, 2019

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Dec 11, 2019

Notice Of Publication

Nov 25, 2019

Approved For Pub - Principal Register

Nov 22, 2019

Application Filing Receipt Mailed

Nov 18, 2019

Assigned To Examiner

Nov 18, 2019

New Application Office Supplied Data Entered In Tram

Nov 14, 2019

Sn Assigned For Sect 66a Appl From Ib